Immunodiagnostic Systems Holdings PLC | Cash Flow
Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
8,335.00
4,053.00
37,023.00
1,191.00
935.00
842
Depreciation, Depletion & Amortization
6,846.00
6,904.00
6,983.00
4,658.00
4,561.00
4,457
Other Funds
1,106.00
34.00
37,814.00
1,625.00
567.00
329
Funds from Operations
14,075.00
10,923.00
7,774.00
7,474.00
4,929.00
5,628
Changes in Working Capital
1,709.00
1,355.00
474.00
1,043.00
2,364.00
232
Net Operating Cash Flow
12,366.00
9,568.00
8,248.00
8,517.00
2,565.00
5,860
Capital Expenditures
6,056.00
6,459.00
5,183.00
4,510.00
4,373.00
Sale of Fixed Assets & Businesses
-
229.00
188.00
712.00
375.00
Net Investing Cash Flow
6,056.00
8,770.00
4,995.00
3,798.00
3,998.00
Cash Dividends Paid - Total
866.00
2,479.00
876.00
353.00
1,177.00
Issuance/Reduction of Debt, Net
-
116.00
410.00
96.00
86.00
Net Financing Cash Flow
918.00
2,546.00
876.00
449.00
1,327.00
Net Change in Cash
7,125.00
2,960.00
2,824.00
4,941.00
2,962.00
Free Cash Flow
10,058.00
6,696.00
6,453.00
7,046.00
831.00
Net Assets from Acquisitions
-
2,540.00
-
-
-
Change in Capital Stock
1,784.00
49.00
410.00
-
64.00
Exchange Rate Effect
103.00
1,212.00
447.00
671.00
202.00
About Immunodiagnostic Systems Holdings
View Profile
